Inovio Pharmaceuticals, Inc.
Short
Updated

[INO] Technically Oversold but Coronavirus Stocks are Volatile

239
INO's narrow, steep channel makes no sense, it'll break below channel line and correct into new downward channel likely falling along with overall market in June.

Avg. cost: $7.28

Sold 20% at $11.63 (~50% profit mark), 20% at $13.30 (~100% profit mark) and 20% at $16.09 today (rough peak estimate). Will hold the remaining 40% just cuz who knows if some trial or study or funding announcement drops but I do expect it to fall back down and would love a chance to re-up here around $10. Even POC (white line) of $13 is probably still a bit overpriced. Dripping in FOMO here.
Note
Climbing the support now!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.